February 1st 2022
Earlier than Expected - DXB Gets First Regulatory Approval in Europe.
October 15th 2021
DXB to run a Phase III COVID-19 Study in Australia
September 24th 2021
DXB announces approval for Phase III COVID-19 trials in India
April 22nd 2021
Bod Australia outlines strong revenue growth
March 18th 2021
Can BDA’s medical cannabis product treat long-COVID symptoms?
March 12th 2021
Australian stock market still the best performing in the world
February 19th 2021
Is Australia spending our grandchildren’s future?
December 17th 2020
Achiko emerges as strong Covid-19 beneficiary
Connect with us
